Authors: Perlstein, I Stepensky, D Sapoznikov, D Hoffman, A

Citation: I. Perlstein et al., Power spectral analysis of heart rate variability in rats as a quantitative tool in the PK-PD analysis of the parasympatholytic activity of atropine, PHARM RES, 18(8), 2001, pp. 1220-1225

Authors: Hoffman, A Stepensky, D Ezra, A Van Gelder, JM Golomb, G

Citation: A. Hoffman et al., Mode of administration-dependent pharmacokinetics of bisphosphonates and bioavailability determination, INT J PHARM, 220(1-2), 2001, pp. 1-11

Authors: Stepensky, D Friedman, M Srour, W Raz, I Hoffman, A

Citation: D. Stepensky et al., Preclinical evaluation of pharmacokinetic-pharmacodynamic rationale for oral CR metformin formulation, J CONTR REL, 71(1), 2001, pp. 107-115

Authors: Ezra, A Hoffman, A Breuer, E Alferiev, IS Monkkonen, J El Hanany-Rozen, N Weiss, G Stepensky, D Gati, I Cohen, H Tormalehto, S Amidon, GL Golomb, G

Citation: A. Ezra et al., A peptide prodrug approach for improving bisphosphonate oral absorption, J MED CHEM, 43(20), 2000, pp. 3641-3652

Authors: Hoffman, A Stepensky, D

Citation: A. Hoffman et D. Stepensky, Pharmacodynamic aspects of modes of drug administration for optimization of drug therapy, CR R THER, 16(6), 1999, pp. 571-639

Authors: Cohen, H Alferiev, IS Monkkonen, J Seibel, MJ Pinto, T Ezra, A Solomon, V Stepensky, D Sagi, H Ornoy, A Patlas, N Hagele, G Hoffman, A Breuer, E Golomb, G

Citation: H. Cohen et al., Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1) - A novel bisphosphonate, PHARM RES, 16(9), 1999, pp. 1399-1406